Skip to main content
Signal8

Patel Jeegar Pravinkumar

SEC insider (Form 3/4/5 filer). CIK 0002092017. Chief Scientific Officer at Evommune, Inc. (EVMN). 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PALO ALTO, CA.

Companies Patel Jeegar Pravinkumar has filed insider reports for

  • Evommune, Inc. (EVMN): Officer, Chief Scientific Officer
Patel Jeegar Pravinkumar profile photo

Patel Jeegar Pravinkumar

CIK: 0002092017

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Evommune, Inc. logo
EVMN

Evommune, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 22, 2026
    Sale
    Direct
    1.5K shares at avg. $22.50$33K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 22, 2026
    Exercise
    Direct
    1.5K shares at avg. $3.84$6K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 1, 2026
    Exercise
    Direct
    13.5K shares at avg. $3.84$52K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 1, 2026
    Sale
    Direct
    16.7K shares at avg. $22.74$379K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Apr 16, 2026
    Award

    Employee Stock Option (Right to Buy)

    Direct
    69.3K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Dec 9, 2025
    Tax Payment
    Direct
    7.5K shares at avg. $17.84$134K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 7, 2025
    Conversion
    Direct
    3.2K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 5, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    179.6K shares-

1-8 of 8